Best TWAS P=7.53e-67 · Best GWAS P=8.81e-98 conditioned to NaN
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Adipose Subcutaneous | SETD9 | 0.15 | 0.14 | lasso | 10 | 0.16 | 3.0e-13 | -7.576 | 5.3 | 1.1e-07 | -0.04 | 1.00 | 0.00 | FALSE |
2 | GTEx | Brain Putamen basal ganglia | SETD9 | 0.23 | 0.15 | lasso | 3 | 0.14 | 2.9e-04 | -9.515 | 8.9 | 5.7e-19 | -0.19 | 0.22 | 0.04 | FALSE |
3 | GTEx | Breast Mammary Tissue | CTD-2310F14.1 | 0.14 | -0.01 | enet | 23 | 0.01 | 6.7e-02 | 6.303 | -7.2 | 6.6e-13 | 0.27 | 0.07 | 0.31 | TRUE |
4 | GTEx | Breast Mammary Tissue (Female) | SETD9 | 0.21 | 0.12 | lasso | 11 | 0.16 | 1.4e-05 | -14.260 | 11.2 | 4.9e-29 | -0.33 | 0.57 | 0.04 | TRUE |
5 | GTEx | Breast Mammary Tissue (Female) | CTD-2310F14.1 | 0.21 | 0.01 | lasso | 6 | 0.02 | 9.4e-02 | 4.875 | -6.0 | 2.2e-09 | 0.26 | 0.05 | 0.55 | TRUE |
6 | GTEx | Cells Transformed fibroblasts | SETD9 | 0.31 | 0.42 | lasso | 6 | 0.47 | 5.7e-39 | 0.440 | 5.7 | 1.3e-08 | -0.06 | 1.00 | 0.00 | FALSE |
7 | GTEx | Spleen | CTD-2310F14.1 | 0.38 | 0.00 | enet | 21 | 0.01 | 2.0e-01 | -16.491 | -17.3 | 7.5e-67 | 0.60 | 0.04 | 0.50 | TRUE |
8 | GTEx | Stomach | SETD9 | 0.35 | 0.31 | lasso | 8 | 0.38 | 1.9e-19 | 0.440 | 5.7 | 1.6e-08 | -0.07 | 1.00 | 0.00 | TRUE |
9 | GTEx | Testis | SETD9 | 0.18 | 0.05 | lasso | 6 | 0.11 | 1.9e-05 | -7.301 | 8.0 | 1.3e-15 | -0.12 | 0.73 | 0.01 | FALSE |
10 | GTEx | Testis | CTD-2310F14.1 | 0.35 | 0.14 | lasso | 8 | 0.15 | 2.9e-07 | -0.064 | -8.1 | 7.8e-16 | 0.12 | 0.94 | 0.00 | FALSE |
11 | METSIM | Adipose | SETD9 | 0.10 | 0.14 | lasso | 17 | 0.16 | 9.6e-23 | -7.310 | 5.4 | 5.5e-08 | -0.04 | 1.00 | 0.00 | FALSE |
12 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C5orf35 | 0.29 | 0.42 | lasso | 8 | 0.46 | 3.0e-107 | 0.440 | 5.2 | 1.8e-07 | -0.07 | 1.00 | 0.00 | FALSE |
13 | The Cancer Genome Atlas | Esophageal Carcinoma | C5orf35 | 0.19 | 0.20 | lasso | 4 | 0.18 | 1.9e-06 | -7.301 | 6.4 | 1.2e-10 | -0.07 | 0.81 | 0.01 | FALSE |
14 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | C5orf35 | 0.27 | 0.30 | lasso | 6 | 0.36 | 1.4e-21 | 0.440 | 5.6 | 2.5e-08 | -0.07 | 1.00 | 0.00 | FALSE |
15 | The Cancer Genome Atlas | Brain Lower Grade Glioma | MIER3 | 0.05 | 0.00 | blup | 81 | 0.01 | 6.2e-02 | -0.117 | -8.0 | 1.0e-15 | 0.31 | 0.03 | 0.12 | TRUE |
16 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | C5orf35 | 0.23 | 0.39 | lasso | 11 | 0.37 | 1.9e-18 | -7.301 | 7.6 | 2.4e-14 | -0.12 | 1.00 | 0.00 | FALSE |
17 | The Cancer Genome Atlas | Lung Adenocarcinoma | C5orf35 | 0.42 | 0.45 | enet | 17 | 0.50 | 3.2e-67 | 0.440 | 5.2 | 2.6e-07 | -0.07 | 1.00 | 0.00 | FALSE |
18 | The Cancer Genome Atlas | Lung Adenocarcinoma | MAP3K1 | 0.02 | 0.01 | blup | 83 | 0.01 | 9.1e-03 | -13.795 | -14.2 | 8.8e-46 | 0.64 | 0.06 | 0.44 | TRUE |
19 | The Cancer Genome Atlas | Skin Cutaneous Melanoma | C5orf35 | 0.23 | 0.08 | blup | 58 | 0.17 | 2.5e-05 | -15.283 | 10.2 | 1.3e-24 | -0.27 | 0.52 | 0.05 | FALSE |
20 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | MIER3 | 0.17 | 0.12 | lasso | 3 | 0.07 | 1.6e-03 | -10.660 | -11.6 | 2.5e-31 | 0.62 | 0.02 | 0.54 | TRUE |
21 | The Cancer Genome Atlas | Thyroid Carcinoma | MAP3K1 | 0.04 | 0.03 | lasso | 2 | 0.03 | 4.4e-04 | -12.627 | -13.4 | 5.6e-41 | 0.62 | 0.09 | 0.63 | TRUE |
22 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | C5orf35 | 0.38 | 0.05 | blup | 58 | 0.06 | 7.0e-03 | -0.117 | 6.5 | 7.9e-11 | -0.09 | 0.13 | 0.04 | TRUE |